NeVa NEWS | Vesalio | United States

Vesalio Receives Peripheral FDA 510k Clearance and Additional CE Approval

Vesalio Receives Peripheral FDA 510k Clearance and Additional CE Approval

Nashville, TN, January 28, 2021 Vesalio reports it has obtained an FDA 510k clearance and its 4th CE approval. The FDA 510k indication is for the removal of thrombi in peripheral blood vessels. The new CE approval expands the NeVa™ neuro-thrombectomy portfolio. Vesalio’s Drop ZoneTM technology, designed to remove the full spectrum of clots from vascular anatomy, has been acclaimed for consistently achieving high first-pass rates, a key parameter associated with better patient

Vesalio Expands Sales Network, Initiates Virtual Training and Announces Pass Effect Rate Publication

Vesalio Expands Sales Network, Initiates Virtual Training and Announces Pass Effect Rate Publication

Nashville, TN, September 16, 2020 Vesalio announces it has executed additional exclusive distribution agreements in Europe, Latin America, Asia, and the Middle East. With these new partnerships, the NeVa™ Thrombectomy System has gained market coverage in 53 countries. “The expansion of the NeVa product line and impressive clinical data are driving strong interest from top distribution companies globally, accelerating our growth momentum. We expect to add additional markets by

Another Successful Vesalio™ Clot Interaction Workshop in Barcelona

Another Successful Vesalio™ Clot Interaction Workshop in Barcelona

On January 22 and 23, a diverse group of physicians from 8 different countries trained on new approaches for clot retrieval with the NeVa™ Drop Zone Retrieval Technique at the Vesalio Clot Interaction Workshops that took place at the Vall d’Hebron Research Institute. Participants started by discovering the design differences of the NeVa Thrombectomy device and how the Drop Zones offer an alternative mechanism of interaction with different types of thrombus. After discussing t

MedTim Presents NeVa in Warsaw

MedTim Presents NeVa in Warsaw

Vesalio’s distributor partner in Poland, MedTim sp. A.o.o. was proud to sponsor #AcuteIschemicStroke courses organized in the Warsaw and Masovian Voivodship hospitals. During the courses (December 6-7, 2019 and January 17-18, 2020), our Polish team presented #NeVa to physicians #thrombectomy and provided hands-on experience using Vesalio’s proprietary silicone flow model. Thanks to all physicians and partners that visited us. #dothedropzone #DoTheDropZone #LeaveNoClotBehind #

Vesalio and BormiaMed partner to Improve Stroke Care in Serbia

Vesalio and BormiaMed partner to Improve Stroke Care in Serbia

Ljiljana Vilovski, of Bormia Medical was joined by Jessica Koradin, Vesalio’s Clinical Training Specialist in Serbia from Dec 9 to 11. Jessica and Ljiljana met with several stroke teams that are preparing to launch 24 hour/ 7 day services in Serbia. Technical discussions arose with interventional neuro-endovascular physicians and stroke team members regarding flow model training of the NeVa #DropZone Technique™. Positive outcomes impressed Serbian stroke teams who are eager t

Vesalio™ Clot Interaction Workshop

Vesalio™ Clot Interaction Workshop

Another successful VESALIO CLOT INTERACTION WORKSHOP was conducted at the Vall d'Hebron Research Institute on the 18th and 19th of November.17 attendees from 10 different countries enjoyed the hands-on practice with the Drop Zone Retrieval Technique, doing thrombectomies with several different clot types. Participants were challenged with very high clot burden situations and hard clots which presented them a chance to practice with the multiple clot interaction capabilities o

Vesalio™ at Serbian Neuro Surgical Society 2019 meeting

Vesalio™ at Serbian Neuro Surgical Society 2019 meeting

Vesalio and Bormia Med were proud to sponsor the 5th SNSS Meeting in Serbia which took place from 24th to 27th October in Kragujevac. The conference was rich with lectures, exchanges, and hands-on training. The event had special significance to the team for marking the debut of NEVA™ launch in Serbia. We would like to thank Dr. Luka Novosel for presenting the rich, positive NEVA™ experience from Zagreb Sister’s Charity Hospital. We also want to thank the Serbian physician co

Like our NeVa portfolio, our team comes in multiple sizes!

Like our NeVa portfolio, our team comes in multiple sizes!

VESALIO and German distribution partner PRISMA PLUS joined forces to exhibit at the 54th annual neuroRAD conference in Frankfurt, October 9-12, 2019. Our teams presented recently approved sizes of NeVa™ thrombectomy devices featuring 3 and 5 Drop Zones and planned clinical with NeVa operators in Germany, Austria and Switzerland. We thank all physicians who stopped by our booth and look forward to further collaboration with you. #DoTheDropZone #NeVa #LeaveNoClotBehind #VESA

Vesalio™ exhibits at Slice 2019

Vesalio™ exhibits at Slice 2019

VESALIO was proud to be a sponsor of the SLICE 2019 congress conducted in Nice, September 30 to October 2, 2019. Vesalio representatives met with existing and potential NeVa users and discussed their clinical cases. Additionally, we were thrilled to view a life-saving NeVa stroke case presented from the podium, describing how our Drop Zone technology was utilized to successfully recanalize a refractory occlusion which had resisted previous passes with a conventional stent re

1st Pass In Stroke With Unknown Onset - Case Report

1st Pass In Stroke With Unknown Onset - Case Report

Right M1 Occlusion 1st Pass Success with NeVa™ M1 (4.0 x 30 mm) 88 year old female patient presented with a NIHSS of 15. The patient was found on the floor of her bathroom, with left side hemiplegia. Her pre-stroke mRS was assessed to be 0. Native CT showed hyperdense M1 segment on the right side. CT angio confirmed M1 occlusion. Click here to read more and see before and after photos of their 1st Pass Success! Thank you Zagreb! #dothedropzone #neva #leavenoclotbehind #ischem

Vesalio™ visible at Esmint 2019

Vesalio™ visible at Esmint 2019

VESALIO was proud to sponsor the ESMINT Society 11th annual meeting in Nice, from 4-6 September 2019. The continued success of the differentiated NeVa™ thrombectomy line as well as the newly approved designs featuring Drop Zone™ technology ensured consistent traffic to the VESALIO exhibit, where the team engaged in fruitful exchanges with physicians. “With our growing team, expanding portfolio and larger footprint, we believe the endovascular stroke space felt how much we hav

A Proximal Occlusion: One and Done - Case Report

A Proximal Occlusion: One and Done - Case Report

Right ICA Tip Occlusion 1st Pass Success with "NeVa T" (4.5 x 37 mm) 75 year old female patient presented with NIHSS of 14. Time from Onset was 1,5 hours at the time of admission to Medical Park stroke center. The patient had a medical history of hypertenssion and atrial fibrillation and was on a once/day regime of Rivaroxaban 20 mg. Imaging confirmed Right ICA Tip occlusion. Professor Dr. Serdar Geyik and the Medical Park Hospital team decided to treat the patient with throm

NeVa™ to the Rescue - Case Report

NeVa™ to the Rescue - Case Report

1st Pass Success with NeVa™ "M1S" (4.0 x 22 mm) after failure of 2 different devices 75 year old female patient presented with NIHSS of 19 presented 4 hours after symptom onset. It was noted that the patient had had a knee implant surgery 3 days prior to her stroke. Imaging confirmed distal left MCA occlusion. Professor Dr. Serdar Geyik and the Medical Park Hospital team decided to treat the patient with thrombectomy. Following the failure of two different brands of 3mm OD st

Wake Up Stroke - Case Report

Wake Up Stroke - Case Report

Left M1 Occlusion 1st Pass Success with NeVa™ "M1" (4.0 x 30 mm) 81 year old male patient presented with NIHSS of 21. The patient was last seen well 6.5 hours ago. Imaging confirmed Left MCA occlusion. Professor Dr. Serdar Geyik and the Medical Park Hospital team decided to treat the patient with thrombectomy using a NeVa "M1" (4.0 x 30mm) under distal aspiration. Click here to read more about this case and see before and after images of their 1st Pass Success! Thank you Ista

Vesalio's Exciting Debut at LINNC 2019

Vesalio's Exciting Debut at LINNC 2019

Vesalio made its exciting debut as an exhibitor at the LINNC congress (Paris, June 3-5). Several current users and many physicians interested in NeVa visited the Vesalio exhibit to discuss recently published First-in-Man study data and view the new, highly innovative NeVa designs approved with Vesalio’s second CE Approval. In attendance at LINNC supporting Vesalio were Igor Bogatec and Vedran Brajkovic from BORMIA, Wout van Breugel from Mermaid Medical and Diane Tangun and Wi

Vesalio Obtains Additional CE Approval for New Products, NeVa™ Clinical Data Published

Vesalio Obtains Additional CE Approval for New Products, NeVa™ Clinical Data Published

Nashville, TN, May 22, 2019 Vesalio announces it has obtained its second CE Approval spanning multiple new NeVa™ product designs and technology. The new generation NeVa devices expand on the Drop Zone™ and Smart Marker™ technologies while also introducing first to market features such as a distal filter. A controlled launch of the new technology will begin in June in Europe with expected full commercial release in Q4 of this year. “We are excited to be granted our second CE A

Vesalio™ Secures $5 Million Investment Capital Funding

Vesalio™ Secures $5 Million Investment Capital Funding

Vesalio announces it has recently raised $5 million in funding. The capital will support the continued global expansion of the NeVa™ Neurothrombectomy System, finance key clinical studies and launch new product introductions. “We are very pleased to secure the additional capital funding, which affirms our track record of achievement and the promising clinical results physicians are seeing with NeVa. We are in the process of initiating several prospective clinical studies for

NeVa™ Drop Zones continue to impress at WLNC

NeVa™ Drop Zones continue to impress at WLNC

VESALIO's™ NeVa attracted interest from the participants from all over the world at the 19th World Live Neurovascular Conference which took place in Barcelona from 1st to 3rd May. Physicians visited the VESALIO booth and discovered the distinct design engineered to improve first pass success with all clot types. During the stroke session on May 3rd, Professor Dr Serdar Geyik (Medical Park Hospital, Istanbul/ TURKEY) presented his outstanding experience with the device and sha

25 new participants trained on “doing the drop zone” at the VESALIO™ CLOT INTERACTION WORKSHOP

25 new participants trained on “doing the drop zone” at the VESALIO™ CLOT INTERACTION WORKSHOP

Three successful VESALIO CLOT INTERACTION WORKSHOPs were conducted at the Vall d'Hebron Research Institute on the 24th, 25th and 26th of April. More than 20 attendees from 11 different countries enjoyed the hands-on practice with the Drop Zone Retrieval Technique, doing thrombectomies with several different clot types. Participants were challenged with very high clot burden situations and fibrin rich clots which presented them a chance to practice with the multiple clot inter

Empowering week in Turkey for Vesalio!

Empowering week in Turkey for Vesalio!

A productive meeting with exceptionally experienced NEVA operator, Prof. Serdar Geyik and his team. We performed the drop zone technique on Vesalio’s Flow model and discussed activities at the upcoming WLNC meeting on May 3rd in Barcelona. Prof. Geyik is encouraged by his very positive results with NEVA. Enjoyable gathering in Eskisehir with 14 physicians from different locations in Turkey. Prof Özdemir shared his experience with NeVa and conducted flow model training to i

CONTACT US